Table 4.
Treatment-emergent adverse events and overall tolerability
TEAEs throughout the study >2%, n (%) | |
---|---|
Total number of patients | 46 (39.7) |
Akathisia | 15 (12.9) |
Anxiety | 12 (10.3) |
Parkinsonism | 7 (6.0) |
Dizziness | 4 (3.5) |
Lethargy | 4 (3.5) |
Insomnia | 3 (2.6) |
Sleep disorder | 3 (2.6) |
Physicians’ impression about overall tolerability, n (%) | |
Very satisfied | 52 (44.8) |
Satisfied | 45 (38.8) |
Neutral | 5 (4.3) |
Dissatisfied | 12 (10.3) |
Very dissatisfied | 2 (1.7) |
TEAEs, treatment-emergent adverse events.